OvaScience Strengthens Management Team To Support Expanding Global Operations

OvaScienceSM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today key changes to the leadership team that will support OvaScience’s expanding global commercial operations.

Arthur Tzianabos, Ph.D., has been promoted to President. Michelle Dipp, M.D., Ph.D., will continue in her role as Chief Executive Officer of OvaScience and has extended her employment contract with the Company.

Help employers find you! Check out all the jobs and post your resume.

Back to news